Skip to content

Efficacy and safety of Platelet Rich Plasma combined with Tai Chi for knee osteoarthritis

Efficacy and safety of Platelet Rich Plasma combined with Tai Chi for knee osteoarthritis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067559
Enrollment
Unknown
Registered
2023-01-11
Start date
2024-02-01
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Group A:intra-articular injection placebo
Group B:intra-articular injection platelet-rich plasma
Group C:Tai Chi combined with intra-articular injection placebo
Group D:Tai Chi combined with intra-articular injection platelet-rich plasma

Sponsors

Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) meet the KOA diagnosis criteria; (2) aged 50–75 years; (3) Kellgren-Lawrence (KL) grade ? to III based on radiographic classification; (4) without the experience of TC; (5) volunteer to take part in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) have the history of trauma, ligament damage, fracture, or surgery on the knee within 12 months, causing pain or functional problems; (2) have severe cardiovascular disease, damage of liver and kidney function, immune deficiency, diabetes mellitus, and blood diseases; (3) have other acute or chronic disorders or psychiatric conditions that will affect physical or cognitive functions; (4) have received medication or relevant intra-articular injection within the last 3 months; (5) have involved in any study related to exercise program within the last 6 months.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index;Referral rate;Retention rate;Drop-out rate;Inflammatory factor in the synovial fluid (IL-1 ß, IL-6 and TNF-a);

Secondary

MeasureTime frame
step length;step velocity;single support time;Knee ROM;knee adduction moment;36-Item Short Form Health Survey;Timed Up and Go test; Inflammatory factor in the venous blood (IL-1 ß, IL-6 and VEGF );

Countries

China

Contacts

Public ContactYang Kun

Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine

akunyang@163.com+86 188 1771 5381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026